AI-powered prediction of binding affinity between drug candidates and protein targets for structure-based drug design.
Our advanced AI infrastructure accelerates your Small Molecule Design workflows with state-of-the-art accuracy.
Run complex simulations and generation tasks instantly on our GPU-accelerated cloud infrastructure.
Built using the latest machine learning models fine-tuned on comprehensive scientific datasets.
Seamlessly integrate this tool with our other Small Molecule Design tools for a continuous pipeline.